A Randomized Trial of Iloperidone for Prevention of Relapse in Schizophrenia: The REPRIEVE Study
Crossref DOI link: https://doi.org/10.1007/s40263-016-0345-4
Published Online: 2016-07-05
Published Print: 2016-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Weiden, Peter J.
Manning, Raymond
Wolfgang, Curt D.
Ryan, J. Michael
Mancione, Linda
Han, Guangyang
Ahmed, Saeed
Mayo, Mallery G.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation and Vanda Pharmaceuticals, Inc.
License valid from 2016-07-05